Carregant...
Botulinum Toxin for Spasticity in Children With Cerebral Palsy: A Comprehensive Evaluation
BACKGROUND: Spasticity is a prevalent disabling clinical symptom for children with cerebral palsy. Treatment of spasticity with botulinum toxin in children with cerebral palsy was first reported in 1993. Botulinum toxin provides a focal, controlled muscle weakness with reduction in spasticity. Inter...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1920182/ https://ncbi.nlm.nih.gov/pubmed/17606561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2007-0016 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|